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mtDNAThe AAA+ Lon protease is a soluble single-ringed homo-oligomer, which represents the most streamlined
operational unit mediating ATP-dependent proteolysis. Despite its simplicity, the architecture of Lon
proteases exhibits a species-speciﬁc diversity. Homology modeling provides insights into the structural
features that distinguish bacterial and human Lon proteases as hexameric complexes from yeast Lon,
which is uniquely heptameric. The best-understood functions of mitochondrial Lon are linked to maintaining
proteostasis under normal metabolic conditions, and preventing proteotoxicity during environmental and
cellular stress. An intriguing property of human Lon is its speciﬁc binding to G-quadruplex DNA, and its
association with the mitochondrial genome in cultured cells. A fraction of Lon preferentially binds to the
control region ofmitochondrial DNAwhere transcription and replication are initiated. Here, we present an over-
view of the diverse functions of mitochondrial Lon, as well as speculative perspectives on its role in protein and
mtDNA quality control. This article is part of a Special Issue entitled: AAA ATPases: structure and function.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
The ATP-dependent Lon protease is highly conserved throughout
all phylogenetic kingdoms from archaea, eubacteria, fungi to
mammalian mitochondria and peroxisomes. Our understanding of
mitochondrial Lon is based largely on studies employing yeast as
well as animal cell systems, which together have demonstrated that
Lon supports cell viability during hypoxic, oxidative and endoplasmic
reticulum (ER) stress [1–3]. In yeast, Lon and m-AAA are the only
ATP-dependent proteases within the mitochondrial matrix, whereas
in metazoans ClpXP is also present (Fig. 1). Together they provide
an integrated surveillance system that monitors mitochondrial
protein quality control. However, their respective functions are not
necessarily redundant. Recent work suggests that Lon and ClpXP
may operate in distinct pathways during adaptive responses to
cellular stressors [1–6]. In addition, mitochondrial Lon is implicated
in the maintenance and expression of mitochondrial DNA (mtDNA),
as a yeast knockout results in large mtDNA deletions and the failureiverse cellular activities; ER,
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l rights reserved.to process mitochondrially-synthesized RNAs that contain introns
[7–9]. In mammals, a sub-population of Lon is associated with
mitochondrial nucleoids [10–12] and interacts with mtDNA in a
sequence-speciﬁc and strand-speciﬁc manner [13–17], binding to
nucleic acid sequences with a propensity to form G-quadruplexes
[16]. In cultured human cells, Lon preferentially binds to the control
region of the mitochondrial genome where transcription and replica-
tion are initiated [15]. In Drosophila cells, Lon has been shown to
degrade mitochondrial transcription factor A (TFAM), which is a
regulator of mtDNA metabolism [18]. This review provides a current
outlook on the biology of mitochondrial Lon.
2. Lon as the simplest ATP-powered proteolytic machine
Lon is distinguished by its simplicity as a soluble, single-ringed
homo-oligomer [19–22]. By contrast, other AAA+ proteases such as
the 26S proteasome, HslUV, ClpP- and FtsH- like proteases are more
complex as they possess multiple sub-assemblies or are membrane-
embedded [23,24]. Fig. 1 shows the ATP-dependent proteolytic
machines within metazoan cells. In the cytosol and nucleus of higher
eukaryotes, the 26S proteasome is the most elaborate AAA+ protease,
consisting of a 20S protease core particle and two 19S regulatory caps
[25–28]. The 20S core is composed of four stacked heptameric rings
that form a barrel-shaped proteolytic chamber, which at both ends are
bound to a 19S regulatory cap. Each 19S cap is further sub-
assembled into a “lid,” which contains ubiquitin-binding subunits
and a “base,” which contains ATPase subunits. Similar to the 26S
proteasome, ClpXP in the mitochondrial matrix is a soluble enzyme
Fig. 1. ATP-dependent proteolytic machines within metazoan cells. The 26S
proteasome is the only non-mitochondrial energy-dependent protease within animal
cells that operates in the cytosol and nucleus. i-AAA and m-AAA are transmembrane
proteases located within the mitochondrial inner membrane (IM) with their catalytic
sites for ATP hydrolysis and proteolysis located within the intermembrane space
(IMS) and matrix, respectively. Lon and ClpXP are soluble proteases within the matrix.
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structural sub-complexes. ClpP consists of identical subunits assem-
bled into two stacked heptameric rings that form a compartmental-
ized proteolytic chamber, which is capped at either end with a
single hexameric ring of ClpX ATPase subunits [29–32]. In the mito-
chondrial inner membrane, m-AAA and i-AAA are transmembrane
complexes that possess catalytic domains with opposing orienta-
tions that face either the matrix or the inter-membrane space, re-
spectively [33–35]. In humans, m-AAA is found as both a homo-
oligomer of AFG3L2 subunits and as a hetero-oligomer of AFG3L2
and paraplegin subunits while i-AAA is composed of YMEL1 sub-
units. However, the precise arrangement and stoichiometry of sub-
units within these complexes are unknown.
Mitochondrial Lon is encoded by a nuclear chromosomal gene and
is translated in the cytosol as a precursor polypeptide that carries an
amino-terminal mitochondrial targeting sequence (MTS) (Fig. 2A)
[36,37]. This sequence directs the translocation of the Lon precursor
across the mitochondrial outer and inner membranes. Upon protein
import into the matrix, the targeting sequence is cleaved off, resulting
in the mature processed protein. The yeast homolog of Lon (Pim1p)
also undergoes an autocatalytic cleavage of its amino-terminus [38].
Each subunit contains three functional domains: the N-terminal
domain (N-domain), the ATPase domain or AAA+ module, and the
protease domain (P-domain) (Fig. 2A). The N-domain exhibits the
highest degree of divergence in both amino acid composition and
length, and is proposed to mediate substrate recognition. Within the
AAA+ module, the Walker Box A and B motifs are responsible for
binding and hydrolyzing ATP. The P-domain shows the highest evolu-
tionary conservation surrounding the proteolytic active site serine
residue [39].
Insights into the structure and function of mitochondrial Lon are
provided by crystal structures of the bacterial holoenzymes from
Bacillus subtilis and Thermococcus onnurineus NA1 (Ton) [21,22], the
truncated protease complex of Escherichia coli Lon [40] as well as
the isolated AAA+ module, N and P domains [41–44]. The structure
of the protease domain complex of E. coli Lon revealed a unique serine
protease that employs a serine-lysine dyad at its active site [40]. Lon
differs from typical serine proteases such as chymotrypsin, which
have a canonical catalytic serine–aspartate–histidine triad at their
active sites. The presence of a serine–lysine dyad is also observed inthe crystal structures of intact holoenzymes of B. subtilis and Ton
Lon [21]. Like other self-compartmentalizing proteases, the active
sites of the six assembled Lon monomers are sequestered within an
aqueous chamber and inaccessible from the exterior. Another
common feature of AAA+ proteases is that ATP or ADP is bound at
the interface between adjacent monomers in the hexamer
[21,22,41,45]. The spatial layout of the TonLon holoenzyme is
described as a “bowl and lid,” in which the interior of TonLon forms
one continuous chamber without apparent gating between the
ATPase and protease domains [21].
Several architectural features of mitochondrial Lon proteases
show distinct species-speciﬁc diversity. Saccharomyces cerevisiae Lon
puriﬁed from mitochondria is a ring-shaped complex with seven
ﬂexible subunits as determined by analytic ultracentrifugation and
cryo-electron microscopy [20]. When puriﬁed in the absence of
added nucleotide, the yeast Lon holoenzyme exhibits a distinct
asymmetry in which two adjacent subunits are in an extended
conformation [20]. The addition of ATP or non-hydrolyzable AMP-
PNP during puriﬁcation, leads to a conformational change and an
increased frequency of symmetric ring-shaped particles. These ﬁnd-
ings suggest that ATP-binding in the absence of hydrolysis promotes
dynamic rearrangements within the holoenzyme. The asymmetry of
yeast Lon as demonstrated by cryo-electron microscopy is signiﬁcant-
ly more pronounced than that observed for B. subtilis Lon or TonLon as
shown by X-ray crystallography. For TonLon, the protease domains
are arranged with a near perfect six-fold symmetry relative to the
axial pore. However, the AAA+ domains show a nucleotide-
dependent asymmetry of the α/β sub-domains that upon nucleotide
exchange are proposed to cause ﬂuctuations in the diameter and
shape of the portal thereby supporting substrate translocation [21].
The ﬁnding that bacterial Lon proteases are hexameric whereas S.
cerevisiae mitochondrial Lon is heptameric, raises the question as to
the oligomeric status of the mammalian holoenzyme. Clues to the
human and yeast complexes are provided by homology modeling
using the B. subtilis Lon structure (PDB 3M6A) as a template (Fig. 3
and legend). Primary sequence alignment modiﬁed by secondary
structural conservation demonstrates that human Lon has 43.3%
identity with B. subtilis Lon (Supplementary Fig. 1), whereas a signif-
icantly lower structural identity is observed with TonLon (36%). The
homology model of human Lon suggests it is a hexameric complex
that has an asymmetric, open-ring arrangement reminiscent of
yeast Lon [20]. When the same homology modeling approach is
applied to S. cerevisiae Lon, it cannot be modeled as a hexamer
(Supplementary Figs. 2 and 3). This is most likely explained by the
primary amino acid sequence of S. cerevisiae Lon, which is ~250
amino acids longer than most bacterial and metazoan Lon sequences.
Speciﬁcally, yeast Lon possesses a highly charged insertion of ~50
amino acids between the AAA+ module and the P domain, which is
absent in bacterial and mammalian Lon sequences (Fig. 2B). The
homology model of yeast Lon monomers into a hexameric complex
suggests that the charged region creates a strong steric hindrance
between neighboring subunits and the non-rectiﬁable clashing of
side chains (Supplementary Figs. 2 and 3). Future studies are required
to test the homology model of human mitochondrial Lon and to solve
the crystal structure of the mammalian holoenzyme.
3. Enzymology of mitochondrial Lon
3.1. Assaying Lon-mediated proteolysis
The proteolytic activity of Lon in its puriﬁed form or in cell and
mitochondrial extracts has been investigated primarily using
ﬂuorogenic peptide and protein substrates. Early studies with E. coli
Lon (or La) employed ﬂuorogenic tetrapeptides such as Glt–Ala–
Ala–Phe–MNA or Suc–Ala–Ala–Phe–MNA [46]. In the absence of
ATP, Lon cleaves these tetrapeptides, albeit weakly, whereas in the
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Fig. 2. (A) Domain structure and functional motifs within the primary amino acid sequence of human mitochondrial Lon. MTS, the mitochondrial targeting sequence of the Lon
precursor protein binds to the mitochondrial outer membrane translocation machinery, which mediates protein import into the matrix. N domain, a highly variable
amino-terminal domain proposed to function in substrate recognition and binding. AAA+ module, composed of the α/β sub-domain, which contains the Walker Box A and B
motifs for ATP -binding and –hydrolysis, in addition to the small α sub-domain. P domain, the protease domain containing the serine (S) and lysine (K) residues forming the
catalytic dyad at the proteolytic active sites. S. cerevisiae Lon contains a 54 amino acid charged region that is present between the AAA+ and protease modules. (B) Alignment of
the primary amino acid sequences that include the Lon AAA+module and P-domain from H. sapiens, S. cerevisiae and B. subtilis. Alignment was performed using Jotun-Hein Method.
The sequence similarity within this region between H. sapiens and S. cerevisiae and B. subtilis is 58% and 49%, respectively. Walker Box motifs A and B are indicated by a blue line; the
highly charged region present in yeast Lon/Pim1p is highlighted in yellow; and the residues forming the serine–lysine dyad are outlined in red.
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stimulated substantially. This demonstrates that ATP hydrolysis is
not required for degrading short unstructured peptides, and that
ATP-binding alone is stimulatory. The degradation of larger protein
substrates by E. coli Lon has been characterized using [3H]- or ﬂuores-
cently labeled- casein, leading to the observation that ATP -binding as
well as -hydrolysis are required for proteolysis [47–50]. Because thesepeptide and protein substrates are commercially available and conve-
nient to use, they are currently being employed by various investiga-
tors to measure mitochondrial ATP-dependent proteolysis in cell or
mitochondrial extracts, and in some cases proteolytic activity is
attributed exclusively to Lon. However, these substrates are not
Lon-speciﬁc and are degraded by other cellular proteases. For
example, the ﬂuorogenic Ala–Ala–Phe peptides are degraded by
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speciﬁcity combined with the relatively poor catalytic efﬁciencies of
Lon for these peptide substrates (kcat/Kmb102 M−1 s−1) limits their
usefulness to biochemical assays with puriﬁed proteases. Similarly,
casein is degraded by a wide variety of mitochondrial and non-
mitochondrial proteases. Thus, ATP-stimulated or ATP-dependent
proteolysis of these reporters in cell and mitochondrial extracts is
by no means a diagnostic signature of Lon activity.
The need for speciﬁc reporter substrates to distinguish Lon-
dependent protease activity led to the development of FRETN 89–98
to study the mechanism of E. coli Lon [53]. FRETN 89–98 consists of
a peptide sequence from the bacteriophage λN protein (amino acid
residues 89–98), which is an endogenous bacterial substrate [54].
Intact FRETN 89–98 carries a carboxyl-terminal anthranilamide ﬂuor-
ophore (donor) that is internally quenched by an amino-terminal
3-nitrotyrosine (acceptor). Upon cleavage of FRETN 89–98, the
donor and acceptor separate from one another leading to increased
ﬂuorescence. Human mitochondrial Lon also degrades FRETN 89–98
and has been used to monitor its proteolytic activity [52]. Although
FRETN 89–98 is also degraded by the 20S proteasome, this activity
is not stimulated by ATP and thus can be distinguished from Lon
[52]. Additional peptide or chemical reporters are required todiscriminate speciﬁc mitochondrial and cytosolic ATP-dependent
protease activities in cellular extracts.
3.2. Functional mechanics of substrate recognition and catalysis by Lon
Our current understanding of substrate selection and cleavage by
Lon proteases is based principally on studies employing the bacterial
enzyme. However, insights into the functional mechanics of mito-
chondrial Lon can be drawn from the bacterial system as human
Lon is able to degrade some bacterial Lon substrates in vitro [52],
and yeast Lon/Pim1p can be functionally replaced by E. coli Lon [55].
Comparing the degradation proﬁles of several endogenous or heterol-
ogous substrates of E. coli Lon led to the postulate that solvent
exposed hydrophobic peptide patches in an unfolded protein function
as recognition tags for the protease [56–59]. In general, deletion of
such tags stabilize proteins that are otherwise degraded by Lon
[57,59–61] and in some cases, protein degradation is initiated by
incorporating a recognition tag into a stable heterologous reporter
protein [57–59]. Some stably folded proteins with accessible recogni-
tion tags are unfolded and degraded by E. coli Lon [58]. However,
other signals or features of substrates that are not hydrophobic in
nature can also target proteins for degradation by bacterial Lon.
Analysis of the peptide sequences within the transcriptional activator
SoxS that are required for Lon-mediated proteolysis show that hydro-
phobicity does not appear to be an essential feature of the sequence
elements identiﬁed [59]. For the cell division inhibitor SulA, the pres-
ence of a single histidine residue at the extreme C-terminus signals its
efﬁcient degradation by E. coli Lon [60]. Studies examining the mech-
anism by which E. coli Lon degrades the DNA binding protein HUβ
show that the recognition and binding sites within this substrate
are independent of the initial cleavage site [62]. Although HUα
and HUβ are both recognized and bound by Lon to the same extent
as determined by rupture force spectroscopy and competition
experiments, only HUβ contains an initiating Lon cleavage site.
Thus, the rules governing recognition and cleavage of physiological
substrates by E. coli Lon are apparently less clear than those identiﬁedFig. 3. Molecular modeling of the human mitochondrial Lon protease. (A) The ribbon
model was generated in PyMol (www.pymol.org). (B) The space-ﬁlling model was
generated in Schrödinger Suite. Models of the human Lon monomer containing the
ATPase and protease domains were initially generated by the CPH server [121],
(http://www.cbs.dtu.dk/services/CPHmodels/), which uses the SEGMOD tool of Gene-
Mine (Molecular Application Group, GeneMine, Palo Alto, CA, formerly known as
XLOOK) [122–124]. SEGMOD divides the target sequence into short segments followed
by searches for homologous structural fragments in Protein Data Bank (PDB). The frag-
ments were then ﬁtted onto the template structure using secondary structure align-
ment and multiple independent models were generated of the entire structure. The
optimal structure was the average of multiple models (GeneMine Manual, pp. 425–
426). The resulting structures were submitted to the PDB to identify protein structures
with highest homology. A sequence alignment was then generated to identify con-
served and deﬁned regions of secondary structure. The secondary structural alignment
demonstrated that human Lon has 43.3% identity with Bacillus subtilis Lon (Supple-
mentary Fig. 1). By contrast, human Lon showed signiﬁcantly lower structural identity
(36%) with Thermococcus onnurineus NA1 (Ton) Lon. Therefore, the crystal structure of
B. subtilis Lon (PDB ﬁle 3M6A) [22], was employed as the template structure to model
human Lon. The loops joining the secondary structures were modeled by searching for
homologous structures in PDB. The side chains were then added using energy con-
straints. The model obtained from the CPH server was reﬁned using Schrödinger
Suite (Schrödinger Inc. LLC, New York, NY). The ‘Prepare Protein’ protocol was used
to assign bond orders and valences of each atom, to add the required hydrogen
atoms and to optimize H-bond and side chain orientations. The resulting monomer
structure was minimized using the ‘Impact’ utility with OPLS2005 force ﬁeld. The qua-
ternary structure model of human Lon was generated by Sybyl (Version X; Tripos As-
sociates, St. Louis, MO). A computer program in Sybyl Programming Language (SPL)
was written to incorporate a C6 symmetry related operation with energy constraints
that limited the steric clash to a distance of 0.5 Å between two side chain atoms at
the interface of adjacent monomers in the complex. In the event of steric clashes, ener-
gy minimization of the side chains was performed using AMBER force ﬁeld and Gestei-
ger–Marshelili charges [125,126]. The ﬁnal model was further subjected to the ‘Protein
Preparation’ Wizard’ tool of Schrödinger Suite. A similar protocol was used to generate
the model for the yeast mitochondrial Lon protease.
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complexity.
Studies with human mitochondrial Lon demonstrate that certain
endogenous protein substrates are recognized only when they are
in a folded functional state and not when they are unfolded [63].
For example, the unassembled α subunit of the mitochondrial proces-
sing peptidase (MPPα) is targeted by Lon only when it is in a native
conformation that is trypsin resistant and capable of forming an ac-
tive enzyme with its partner MPPβ. The initial cleavage sites within
MPPα are at hydrophobic residues within structured regions that
are exposed at the surface of the folded protein and surrounded by
a highly charged environment. Interestingly, these initiating cleavage
sites are not masked at the interface where MPPα is complexed with
MPPβ. These ﬁndings suggest that substrate recognition by human
mitochondrial Lon is not restricted to abnormal proteins that are mis-
folded or damaged.
The potential cleavage of a folded protein or structured region by
mitochondrial Lon raises the question of how such substrates gain
access to the active site of the protease where they can be initially
clipped thereby leading to subsequent unfolding and degradation.
One possibility offered by the structures of bacterial and yeast Lon is
that a ring-opening mechanism within the enzyme permits access
of structured regions or small folded proteins to the proteolytic
chamber [20–22]. However, other possibilities are that the substrate
is locally unfolded before translocation to the active site of the
protease, or that multiple polypeptide chains simultaneously pass
through the pore as has been observed for bacterial ClpXP [64].
The general paradigm for ATP-dependent proteolysis likely applies
to the mitochondrial Lon protease (Fig. 4) [65–69]. The N-domain and
AAA+ module of the holoenzyme ﬁrst recognize and bind a speciﬁc
recognition determinant or site within a protein substrate in an ATP-
independent manner (step 1). ATP -binding and -hydrolysis drive
conformational changes within the enzyme complex that unfold sub-
strate polypeptides (step 2), and also power the translocation of the
denatured substrates into the proteolytic chamber, which is seques-
tered from the surrounding aqueous environment (step 3). Once the
unfolded substrate is accessible to the proteolytic active sites, peptide
bond cleavage occurs (step 4). Substrate unfolding and translocation
are proposed to constitute the rate-limiting steps of the reaction [70]
through repetitive cycles of ATP hydrolysis that induce conformation-
al changes within the protease [71,72]. Translocation of substrate is
hypothesized to occur by a threading mechanism [68,73]. For certain
substrates of ATP-dependent proteases, proteolytic digestion gener-
ates peptides ranging from ~5 to 20 amino acids and not a variety ofFig. 4. General paradigm for the recognition and degradation of protein substrates by the Lo
protein substrate. Step 2, unfolding of structured protein substrates by the AAA+ domains o
peptides bypass this step. Step 3, translocation of unfolded polypeptides or short peptide seq
Step 4, peptide bond cleavage resulting in the generation of small peptide products. Reitera
completely.partially digested polypeptide intermediates, leading to the conclu-
sion that degradation proceeds processively [26,54,63,65,74].
Transient kinetic techniques have been employed to elucidate the
timing mechanism of bacterial Lon-mediated catalysis using the
ATP-dependent peptide bond cleavage of FRETN 89–98 and its
dansylated analog [75,76]. Such studies have yet to be performed
with human Lon. Although FRETN 89–98 is an unstructured decapep-
tide, its cleavage by Lon exhibits comparable ATP-dependency as the
full-length native λN protein. Kinetic studies have been performed by
monitoring peptide bond cleavage by ﬂuorimetry and the ﬁrst
turnover of ATP hydrolysis by radiometry under identical reaction
conditions, thereby permitting the determination of catalytic rate
constants. ATP hydrolysis occurred within the same time frame as
substrate translocation prior to peptide bond cleavage. Thus,
substrate translocation is the rate-limiting step in FRETN 89–98 cleav-
age, which is coupled to ATP hydrolysis. As substrate translocation
and peptide bond cleavage is sustained by the non-hydrolyzable
analog AMP-PNP (albeit with reduced efﬁciency), and inhibited by
ADP, it is proposed that Lon undergoes conformational changes
when bound to different adenine nucleotides, which power the
movement of substrate into the proteolytic chamber [75].
4. Selective protein degradation by mitochondrial Lon in yeast
and mammals
4.1. Degradation of misfolded, unassembled and damaged proteins
Lon-mediated proteolysis is essential for mitochondrial function
and cellular homeostasis. Studies in S. cerevisiae demonstrate that
yeast strains lacking the homolog of Lon referred to as Pim1p fail to
grow on non-fermentable carbon sources, suffer large mtDNA
deletions, exhibit reduced ATP-dependent proteolysis and accumu-
late electron dense aggregates in the mitochondrial matrix [7,8].
Some of these phenotypes are also observed in S. pombe strains
lacking the Lon protease [77]. Early clues that Pim1p participates in
mitochondrial protein quality control arose from the ﬁnding that
unassembled subunits of the F1 ATPase and mitochondrial ribosomal
proteins (MRPs) are degraded in control yeast strains expressing
Pim1p but not in Δpim1 strains lacking the protease [7,78]. Like the
Δpim1 mutant, the matched control strains carry large mtDNA
deletions, and therefore do not produce mitochondrially-encoded
subunits of respiratory complexes or mitochondrial ribosomes. In
the absence of these proteins, partner subunits imported into the
mitochondrial matrix fail to assemble properly and are selectivelyn protease. Step 1, recognition and binding of a structural feature or sequence within a
f the holoenzyme, which requires ATP -binding and -hydrolysis. Unfolded substrates or
uences into the degradation chamber, which also requires ATP -binding and -hydrolysis.
tive rounds of substrate unfolding and translocation are required to degrade substrates
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Pim1p-mediated proteolysis requires the cooperation of the mito-
chondrial chaperones Ssc1p (mtHsp70) and Mdj1p [79], or Hsp78p
[80–82]. These mitochondrial chaperones mediate protein disaggre-
gation and maintain substrates in an unfolded state, thereby promot-
ing Pim1p-mediated proteolysis.
In S. cerevisiae and the ﬁlamentous fungi Podospora anserina,
Pim1p/Lon plays an important role in the defense against environ-
mental stressors such as oxidative stress and elevated temperature
[77,84,86,89]. Steady state levels of Pim1p are increased by the
oxidizing agent H2O2 or by heat shock at 42 °C, whereas the
mitochondrial inner membrane m-AAA proteases, Yme1p and
Yta10p show little or no change in protein expression under these
conditions [86]. A Δpim1 strain is growth inhibited when grown in
the presence of H2O2 or menadione, which induce reactive oxygen
species (ROS) [84,86]. When Pim1p is overexpressed, the aggregation
of mitochondrial aconitase (Aco1p) is prevented [86]. In P. anserina,
the constitutive overexpression of Podospora Lon (PaLon) leads to
lower levels of carbonylated aconitase and carboxymethylated
proteins, reduced secretion of hydrogen peroxide and increased
resistance to oxidative stress. An interesting observation in P. anserina
is that overexpressing PaLon extends lifespan with no apparent
defects in respiration, growth or fertility [89].
S. cerevisiae provides a simpliﬁed system for studying Pim1p/Lon
function as this organism lacks ClpP. Global proteomic analyses
using mitochondrial extracts isolated from Δpim1 yeast and control
strains have identiﬁed protein substrates of Pim1p [83,84]. The ﬁrst
proteomics studies identiﬁed seven metabolic enzymes as Pim1p
substrates- Ilv1, Ilv2, Lsc1, Lys4 and Yj1200c [83,85], Prx1 and Ilv3
[86]. The import of radiolabeled precursor proteins into isolated con-
trol or Δpim1 mitochondria was performed to determine the kinetics
of substrate degradation. In control mitochondria containing Pim1p,
~50–90% of the newly imported precursor proteins are degraded
after 4 h in an ATP-dependent manner, whereas in Δpim1 mitochon-
dria only ~20–50% of imported proteins are degraded [83,85,86].
Several of the Pim1p substrates identiﬁed contain a prosthetic
group or cofactor. Lys4, Ilv3 and Yj1200c are known Fe/S cluster-
containing proteins; Ilv1 requires pyroxidal pyrophosphate as a
cofactor, and Ilv2 requires thiamine pyrophosphate. Although Lsc1
contains neither a prosthetic group nor cofactor, it is a subunit of a
heterodimeric enzyme complex. One possibility is that these proteins
are susceptible to Pim1p-mediated proteolysis if they are improperly
associated with their respective cofactors or partner proteins.
Another possibility is that some cofactors such as Fe/S clusters are
not only vulnerable to oxidative damage but they can also promote
oxidative stress when destabilized, leading to the generation of
oxygen radicals through Fenton chemistry. Notably however, the
Fe/S cluster protein mitochondrial aconitase (Aco1p) does not
accumulate in Δpim1 mitochondria [83,84], nor is its turnover
signiﬁcantly altered upon import into isolated Δpim1 mitochondria
[83]. Consistent with these ﬁndings, a knockout of Lon in S. pombe
does not exhibit altered aconitase activity or increased levels of
reactive oxygen species (ROS) [77]. Another proteomics study was
undertaken to identify oxidized proteins that accumulate in Δpim1
mitochondria [84]. An oxidation index value was assigned to the
various accumulated proteins, and was deﬁned as fold increase in
oxidized protein/total protein in Δpim1 versus control mitochondria.
The proteins with values >1.15, were considered Pim1p substrates:
Ald4 (1.15) Atp2 (1.29), Ldp1 (1.54), Sod2 (1.19), Pdb1 (1.99),
Hsp60 (2.09), Ilv5 (5.22). Ilv5 was shown previously to be a substrate
of Pim1p [80]. In this study, oxidized Aco1p was not amongst the
proteins accumulating in Δpim1 mitochondria.
Inmammalian cells, Lon-mediated proteolysis has been implicated
in the selective degradation of oxidized aconitase [87,90]. In one
study, partially puriﬁed mitochondrial aconitase was tritium-
radiolabeled (3H-aconitase) and treated with or without H2O2 atmillimolar concentrations and then dialyzed before reacting with
mitochondrial extracts or puriﬁed Lon. Results suggest that Lon selec-
tively degrades the 3H-aconitase preparation exposed to 2.5–5 mM
H2O2. Resistance to Lon-dependent proteolysis of 3H-aconitase
treated with ≥10 mM H2O2 is observed, possibly as a result of
increased protein aggregation and hydrophobicity [87]. In addition,
the down-regulation of Lon in human ﬁbroblasts correlates with
decreased breakdown of the 3H-aconitase preparation [87]. The
relationship between Lon protein levels and oxidized aconitase was
examined in skeletal muscle of young versus oldmice that were either
wild-type (Sod2+/+) or heterozygous (Sod2−/+) for themitochondri-
al manganese superoxide dismutase. Lon protein levels are lower in
tissue extracts from old animals regardless of Sod genotype, as well
as from young animals that are Sod2−/+; decreased Lon protein is
associated with increased levels of carbonylated protein presumed
to be aconitase [90].
Although human Lon may degrade oxidatively damaged proteins,
results also show that Lon itself is vulnerable to oxidative inactiva-
tion. In isolated non-synaptic rat brain mitochondria, peroxynitrite
(ONOO−) blocks the ATP-stimulated protease activity of Lon by 75%,
whereas ATP-independent activity is inhibited by 45% [91]. In
addition, puriﬁed Lon is inactivated by H2O2 treatment [15]. The
ATPase activity of puriﬁed Lon is blocked by 80% at 100 μM H2O2,
and by 100% at >500 μM. In addition, yeast mitochondrial Lon is
also strongly inhibited by the alkylating agent N-ethylmaleimide
(NEM) [92]. Inhibition of mitochondrial Lon by NEM likely occurs by
alkylation of cysteine residues resulting in enzyme inactivation.
Thus, more thorough studies are required to evaluate the redox
regulation of Lon and its quality control function in response to oxida-
tive stress.
4.2. Protein quality control in the mitochondrial matrix— a division of
labor in metazoans?
Although the role of Lon in protein quality control is one of its best
demonstrated physiological functions, interestingly, it does not
appear to be required for mediating the unfolded protein response
in mitochondria (UPRMT), nor to be up-regulated by this pathway.
In cultured mammalian cells and worms, ClpXP plays a central role
in controlling and responding to the UPRMT (Fig. 5) [4–6,93,94]. By
contrast, Lon does not appear to be an essential participant in this
stress response pathway [93,95,96]. In cultured mammalian cells,
the accumulation of an aggregation-prone protein within the
mitochondrial matrix leads to the transcriptional up-regulation of
ClpP [93,94,96]. The ClpP gene carries mitochondrial unfolded protein
response elements (MURE1 and MURE2) in its promoter region,
whereas the LONP1 gene lacks these promoter sequences. In
Caenorhabditis elegans, studies show that ClpXP is required to initiate
the UPRMT stress response pathway leading to the transcriptional
up-regulation of UPRMT genes in the nucleus such as ClpP and the
mitochondrial DnaJ-like protein Tid1 [4–6] (see Fig. 5 and legend).
By contrast, Lon does not play a notable role in UPRMT, as knocking
down the worm homolog has no effect on this cell stress response
pathway [95].
Although Lon does not appear to have a major function in the
UPRMT, its role in the UPRER has been suggested. Lon expression is
up-regulated in response to protein misfolding or increased protein
burden in the ER, which is induced by either tunicamycin- a glycosyl-
ation inhibitor, thapsigarin— an ER Ca2+ ATPase inhibitor, or brefeldin
A— an inducer of retrograde trafﬁc of Golgi proteins to the ER; all of
these agents activate UPRER [3]. Results show that UPRER-stimulated
Lon overexpression is dependent on the PKR-like ER-localized eIF2α
kinase (PERK), which is speciﬁcally activated by UPRER [3]. In addition,
hypoxia, which also induces ER-stress, has been shown to up-regulate
Lon (see next section). One potential reason why the UPRER may
up-regulate Lon in mitochondria is that the PERK-dependent block
αβ
α
Fig. 5. Regulation of Lon and ClpXP in the ER and mitochondrial unfolded protein responses. (1) Consequences of the unfolded protein response in the ER (UPRER). (1a) The
accumulation of unfolded or misfolded proteins in the ER lumen activates PERK (protein kinase RNA-like endoplasmic reticulum kinase), which phosphorylates and thereby inhibits
the translation initiation factor eIF2α. (1b) A block in eIF2α-dependent translation leads to the selective reduction of cytosolic protein synthesis, which includes proteins imported
into mitochondria. (1c) The reduction in proteins imported into the matrix may result in a stoichiometric imbalance of mitochondrial proteins that must assemble to form functional
complexes. (1d) Signals originating from the cytosol or the mitochondrion may transcriptionally up-regulate the LONP1 gene by an unknown mechanism. (1e) Alternatively,
accumulation of unfolded proteins in the ER directly activates the translation of the transcription factor XBP1 (X-box binding protein 1), which translocates to the nucleus and
may activate LONP1 expression by binding to a putative UPRE (unfolded protein response element), which has yet to be identiﬁed. (1f) Hypoxia is a physiological inducer of ER stress
that has been shown to up-regulate Lon expression by the activation of HIF-1α (hypoxia-inducible factor 1α), which binds to HREs (hypoxia response element) within the promoter
of LONP1. (1g) The resulting increase of Lon may function to re-establish mitochondrial homeostasis. (2) Consequences of the unfolded protein response in the mitochondria (UPRMT).
(2a) Accumulation of unfolded or misfolded proteins that tax the protein quality control capacity of mitochondria lead to the UPRMT, which is initiated by ClpXP-dependent
degradation of protein substrates thereby generating peptides that are efﬂuxed from thematrix to the cytosol by the HAF-1 transporter located in themitochondrial innermembrane.
(2b) The efﬂuxed peptides activate the transcription factors (ZC376.7 and possibly the CHOP/C/EBPβ heterodimer), which then translocate into the nucleus, binding to MURE and
CHOP sequences up-regulating the expression of UPRMT related genes encoding ClpP, mtHsp70, mtHsp60, mtHsp10, and mtDnaJ. (2c) The increased expression of ClpP relieves
mitochondrial stress and re-establishes mitochondrial homeostasis.
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leading to the stoichiometric imbalance of proteins produced in the
cytosol versus themitochondrion, thereby causing proteinmisfolding,
misassembly and aggregation. Lon-mediated degradation may
function to relieve the load of abnormal mitochondrial proteins
caused by the UPRER.
4.3. Lon-mediated proteolysis as a regulatory mechanism
In addition to protein quality control, Lon-dependent degradation
also operates to regulate mitochondrial pathways by terminating the
activity of speciﬁc proteins, or by modulating the activity of protein
complexes by selective subunit degradation. During hypoxia, Lon
participates in remodeling cytochrome c oxidase (COX) holoenzyme
by selectively degrading the Cox4-1 subunit [2]. When oxygen
availability is low, the hypoxia-inducible transcription factor HIF-1α
binds to hypoxia response elements (HRE) in the promoter of the
LONP1 gene leading to Lon up-regulation and Cox4-1 degradation.
At the same time, HIF-1α also up-regulates an alternate isoform-
Cox4-2, which is assembled into the COX complex replacing Cox4-1.
Results demonstrate that Cox4-2 containing complexes are better op-
timized for transferring electrons and increasing the efﬁciency of res-
piration in hypoxic cells [1–3]. In yeast and mammalian cells, both
wild type Lon and a protease-deﬁcient mutant of Lon promote the as-
sembly of COX complexes [3,78], suggesting that Lon may have a
chaperone-like function in the assembly and perhaps disassembly ofproteins. It is tempting to speculate that this function of Lon is
exploited in the selective degradation of Cox4-1 and coordinate
assembly of Cox4-2, which occurs during the hypoxia-induced
remodeling of the COX holoenzyme. In cells of the adrenal cortex,
placenta and gonads, Lon degrades the steroidogenic acute regulatory
protein (StAR), which mediates the rate limiting steps in steroid
hormone synthesis [97]. StAR is required for the transfer of cholester-
ol from the mitochondrial outer membrane to the ﬁrst steroidogenic
enzyme, which is localized on the matrix side of the inner membrane
[97]. The precise mechanism underlying StAR-dependent cholesterol
transfer remains unclear. However, when its mitochondrial matrix
targeting sequence is deleted, StAR can still carry out its essential
function, which appears paradoxically to occur outside of mitochon-
dria [98,99], and its translocation into the mitochondrial matrix
terminates its activity [97]. Within mitochondria, Lon is principally
responsible for the degradation of StAR [97] and may thus provide a
mechanism for regulating the synthesis of steroid hormones. In
addition, recent work demonstrates that Lon degrades alpha aminole-
vulinic acid synthase 1 (ALAS-1), which is the rate-limiting enzyme in
the heme biosynthesis pathway. Accumulation of intracellular heme
down-regulates ALAS-1 by a negative feedback loop that involves
transcriptional repression, mRNA degradation, and blockade of
mitochondrial ALAS-1 protein import [100–102]. Increased levels of
heme also promote the Lon-dependent degradation of mature
ALAS-1 in the mitochondrial matrix [103], and may thereby contrib-
ute to regulating heme biosynthesis. In Drosophila cells, Lon degrades
Fig. 6. Relative locations within the mitochondrial genome of predicted
G-quadruplexes and Lon binding. The positions of G-quadruplexes within the heavy-
strand of human mtDNA (NC_001807) were predicted using Quadﬁnder Version 1
(http://miracle.igib.res.in/quadﬁnder/) [16]. The mtDNA regions bound by Lon in cul-
tured HeLa cells were determined by mtDNA immunoprecipitation (mIP) [15].
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down Lon coordinately increases TFAM protein levels and mtDNA
copy number. Conversely, Lon overexpression reduces TFAM levels
as well as mtDNA copy number [18]. In Lon knockdown cells the
levels of transcription factor B2 of mitochondria (TFB2M) were also
elevated, suggesting that it may also be a substrate of Lon [18].
These results support the concept that Lon-mediated proteolysis
functions as a mechanism for regulating essential rate-limiting and
metabolic processes within mitochondria. However, the substrate
recognition mechanisms that specify Lon-mediated degradation of
Cox4-1, StAR, ALAS-1 and TFAM have yet to be determined.
5. Lon as a mitochondrial DNA binding protein
The association of Lon with DNA is a property of the protease
that is conserved from bacteria to mammalian mitochondria
[13–17,104–111]. Puriﬁed bacterial Lon binds both single-stranded
DNA (ssDNA) and double- stranded DNA (dsDNA), with sequence-
speciﬁcity as shown in one study [110] and non-speciﬁcally in other
studies [106–108,111,112]. By contrast, puriﬁed mammalian mito-
chondrial Lon interacts only with ssDNA, and binds to nucleotide
sequences within the mitochondrial genome in a sequence-speciﬁc
and strand-speciﬁc manner [13,14,16,17]. Human Lon associates
with mitochondrial DNA (mtDNA) sequences bearing at least 4
contiguous guanine residues that have a propensity for forming
G-quadruplexes, which are four-stranded intra- or inter-molecular
structures with a tetrad arrangement of guanines [13,14,16]. Every
~150 nucleotides within the heavy-strand of mtDNA there are 4–6
adjacent guanine residues that can potentially interact to form such
higher ordered structures. Biochemical and biophysical analyses
demonstrate that human Lon binds to mtDNA sequences that form
parallel G-quadruplexes, and that this interaction exhibits a large
negative heat capacity change, which is a thermodynamic signature
of sequence-speciﬁcity [16].
The binding of human Lon to mtDNA is a physiological function of
the protease as demonstrated by mtDNA immunoprecipitation (mIP)
experiments in cultured cells [15]. One principal advantage of mIP is
that it provides a snapshot of protein interaction to mtDNA in a
physiological setting. Human Lon binds preferentially to the displace-
ment loop (D-loop) or control region of mtDNA [15] (Fig. 6), which is
the only non-coding region of the mitochondrial genome containing
the promoters for heavy- and light- strand transcription and one ori-
gin of replication. Lon binding is also observed at other regions of
mtDNA (Fig. 6). Bioinformatic analyses of the mtDNA sequences
pulled down by Lon in mIP assays reveals a G-rich consensus
sequence consistent with DNA footprinting of puriﬁed Lon bound to
a ssDNA oligonucleotide [15]. Consistent with biochemical data, the
regions of mtDNA associated with Lon correspond to regions bearing
predicted G-quadruplex DNA (Fig. 6). Not all regions of mtDNA
predicted to adopt G-quartet structures were found to co-purify
with Lon. At least four variables inﬂuence Lon binding to G-rich
sites in the mIP assay: 1) G-quadruplex formation is inﬂuenced by
the single- or double- stranded state of mtDNA, 2) G-quadruplex
binding by other proteins may block Lon interaction, 3) Lon binding
to speciﬁc G-quartets may depend on ﬂanking sequences, and 4)
the afﬁnity or total number of Lon binding sites with a speciﬁc mIP
ampliﬁcation region is variable.
The importance of G-quadruplexes within the mitochondrial ge-
nome has not been studied. However, G-quadruplexes have been
demonstrated in the promoter regions of nuclear genes in humans,
and may either enhance or block transcription [113,114]. Such
G-quartets are also predicted within the E. coli genome, showing
predominance within promoters of genes linked to transcription,
secondary metabolite biosynthesis, and signal transduction [115].
One can envisage that association of Lon with G-quadruplexes within
the mitochondrial genome provides a mechanism for recruiting theprotease to speciﬁc sites where it can degrade or process proteins
involved in mtDNA and mtRNA metabolism. The association of Lon
with these higher order DNA structures may impart pause sites that
function as checkpoints during replication, transcription or translation.
In addition, the binding of mtDNA by Lon may directly inhibit or pro-
mote the processivity or timing of replication and/or transcription.
Human Lon has been identiﬁed as a protein component of
mitochondrial nucleoids [12], which are multi-protein complexes of
mtDNA maintenance factors that support genomic stability, inheri-
tance and expression. Lon may interact with the mitochondrial
genome through direct as well as indirect interactions. Lon is thus
poised to degrade and regulate proteins mediatingmtDNA replication
and expression, and to remodel mitochondrial nucleoids. Although
mtDNA binding by Lon in cultured cells has been established, the
function of Lon at the mitochondrial genome remains unclear. Results
show that Lon degrades transcription factor A of mitochondria
(mt-TFA, TFAM), and modulates mtDNA copy number [18]. Lon-
mediated degradation of TFAM may be a protein quality control
mechanism for eliminating misfolded or damaged TFAM, and/or a
regulatory mechanism for controlling mtDNA metabolism.
6. Mitochondrial Lon and links to disease
Protein misfolding and aggregation are associated with a variety
of human diseases and aging [116–120], which have been linked to
the increased generation of reactive oxygen species (ROS) and
perturbations in cellular redox status. Mitochondrial proteins are at
an increased risk of oxidative damage and conformational defects as
Table 1
Expression of mitochondrial Lon in various human diseases.
Disease Cause Fold change Method of analysis References
Myoclonic epilepsy and ragged-red ﬁbers
(MERRF) syndrome
mtDNA mutation A8344G in tRNALys 2 fold increase 2D gel, mass spectrometry [127]
Myopathy, encephalopathy, lactic acidosis,
stroke-like episodes syndrome (MELAS)
mtDNA mutation A3243G in tRNALeu(UUR) 2–3 fold increase Mass spectrometry and
immunoblotting
[128]
Friedreich ataxia (FRDA) Defect in mitochondrial frataxin >2.5 fold increase Immunoblotting and RT-PCR [88]
Non-small-cell lung cancer (NSCLC) Multiple (tobacco, asbestos, pollution,
gene mutation etc.)
2–5 fold increase Immunoblotting [129]
Lipodystrophy Side effect of HAART Increase Microarray and immunoblotting [130]
Familial amytrophic lateral sclerosis (fALS) Mutations in copperzinc superoxide
dismutase (SOD1) gene
3-fold decrease 2D gel, mass spectrometry [131]
Hereditary spastic paraplegia (SPG13) Axon degeneration in speciﬁc motor
neurons, gene mutations
~40–50% decrease Immunoblotting and RT-PCR [132]
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powerful source of ROS. In addition, genetic mutations that cause the
misfolding of mitochondrial proteins likely induce the expression or
activity of mitochondrial AAA+ proteases. Mitochondrial Lon is
implicated in various diseases or disease models where its expression
levels are either up- or down- regulated. Table 1 summarizes some of
these experimental ﬁndings.
7. Outlook
Understanding the structural dynamics and functional versatility
of Lon and other mitochondrial AAA+ proteases are broad challenges
for the future. The importance of energy-dependent proteases is not
restricted to protein quality control but also extends to regulating
constitutive metabolism and adaptive responses to cellular stress
and transformation. The development of pharmacological tools as
well as cell culture and animal models to study the biochemical and
biological mechanisms of mitochondrial AAA+ proteolysis is a high
priority in elucidating how these molecular machines support the
integrated network of metabolic reactions at the cellular and
organismal level.
Supplementary materials related to this article can be found
online at doi:10.1016/j.bbamcr.2011.11.003.
Acknowledgements
We thank members of our labs, collaborators and all those who
have contributed to our understanding of the Lon protease. Many
thanks to Dr. F.J. Monsma Jr. for his artistic contributions. Space
limitations have restricted a full discussion of studies investigating
bacterial Lon proteases. This work was funded in part by grants from
the National Institutes of Health (R01GM084039, R21NS067668)
and the Foundation of UMDNJ to C.K.S; and by the National Science
Foundation (MCB-0919631) to I.L.
References
[1] D.A. Bota, K.J. Davies, Protein degradation in mitochondria: implications for
oxidative stress, aging and disease: a novel etiological classiﬁcation of
mitochondrial proteolytic disorders, Mitochondrion 1 (2001) 33–49.
[2] R. Fukuda, H. Zhang, J.W. Kim, L. Shimoda, C.V. Dang, G.L. Semenza, HIF-1
regulates cytochrome oxidase subunits to optimize efﬁciency of respiration in
hypoxic cells, Cell 129 (2007) 111–122.
[3] O. Hori, F. Ichinoda, T. Tamatani, A. Yamaguchi, N. Sato, K. Ozawa, Y. Kitao, M.
Miyazaki, H.P. Harding, D. Ron, M. Tohyama, M.S. D, S. Ogawa, Transmission of
cell stress from endoplasmic reticulum to mitochondria: enhanced expression
of Lon protease, J. Cell Biol. 157 (2002) 1151–1160.
[4] C.M. Haynes, K. Petrova, C. Benedetti, Y. Yang, D. Ron, ClpP mediates activation
of a mitochondrial unfolded protein response in C. elegans, Dev. Cell 13 (2007)
467–480.
[5] C.M. Haynes, D. Ron, The mitochondrial UPR — protecting organelle protein
homeostasis, J. Cell Sci. 123 (2010) 3849–3855.[6] C.M. Haynes, Y. Yang, S.P. Blais, T.A. Neubert, D. Ron, The matrix peptide
exporter HAF-1 signals a mitochondrial UPR by activating the transcription
factor ZC376.7 in C. elegans, Mol. Cell 37 (2010) 529–540.
[7] C.K. Suzuki, K. Suda, N. Wang, G. Schatz, Requirement for the yeast gene LON in
intramitochondrial proteolysis and maintenance of respiration, Science 264
(1994) 273–276.
[8] L. Van Dyck, D.A. Pearce, F. Sherman, PIM1 encodes a mitochondrial ATP-
dependent protease that is required for mitochondrial function in the yeast
Saccharomyces cerevisiae, J. Biol. Chem. 269 (1994) 238–242.
[9] L. van Dyck, W. Neupert, T. Langer, The ATP-dependent PIM1 protease is
required for the expression of intron-containing genes in mitochondria, Genes
Dev. 12 (1998) 1515–1524.
[10] M. Kucej, R.A. Butow, Evolutionary tinkering with mitochondrial nucleoids,
Trends Cell Biol. 17 (2007) 586–592.
[11] X. Cheng, T. Kanki, A. Fukuoh, K. Ohgaki, R. Takeya, Y. Aoki, N. Hamasaki, D. Kang,
PDIP38 associates with proteins constituting the mitochondrial DNA nucleoid,
J. Biochem. 138 (2005) 673–678.
[12] D.F. Bogenhagen, D. Rousseau, S. Burke, The layered structure of human
mitochondrial DNA nucleoids, J. Biol. Chem. 283 (2008) 3665–3675.
[13] G.K. Fu, D.M. Markovitz, The human LON protease binds to mitochondrial
promoters in a single-stranded, site-speciﬁc, strand-speciﬁc manner,
Biochemistry 37 (1998) 1905–1909.
[14] T. Liu, B. Lu, I. Lee, G. Ondrovicova, E. Kutejova, C.K. Suzuki, DNA and RNA
binding by the mitochondrial lon protease is regulated by nucleotide and
protein substrate, J. Biol. Chem. 279 (2004) 13902–13910.
[15] B. Lu, S. Yadav, P.G. Shah, T. Liu, B. Tian, S. Pukszta, N. Villaluna, E. Kutejova, C.S.
Newlon, J.H. Santos, C.K. Suzuki, Roles for the human ATP-dependent Lon
protease in mitochondrial DNA maintenance, J. Biol. Chem. 282 (2007)
17363–17374.
[16] S.H. Chen, C.K. Suzuki, S.H. Wu, Thermodynamic characterization of speciﬁc
interactions between the human Lon protease and G-quartet DNA, Nucleic
Acids Res. 36 (2008) 1273–1287.
[17] B. Lu, T. Liu, J.A. Crosby, J. Thomas-Wohlever, I. Lee, C.K. Suzuki, The
ATP-dependent Lon protease of Mus musculus is a DNA-binding protein that is
functionally conserved between yeast and mammals, Gene 306 (2003) 45–55.
[18] Y. Matsushima, Y. Goto, L.S. Kaguni, Mitochondrial Lon protease regulates
mitochondrial DNA copy number and transcription by selective degradation of
mitochondrial transcription factor A (TFAM), Proc. Natl. Acad. Sci. U. S. A. 107
(2010) 18410–18415.
[19] S.C. Park, B. Jia, J.K. Yang, D.L. Van, Y.G. Shao, S.W. Han, Y.J. Jeon, C.H. Chung, G.W.
Cheong, Oligomeric structure of the ATP-dependent protease La (Lon) of
Escherichia coli, Mol. Cell 21 (2006) 129–134.
[20] H. Stahlberg, E. Kutejova, K. Suda, B. Wolpensinger, A. Lustig, G. Schatz, A. Engel,
C.K. Suzuki, Mitochondrial Lon of Saccharomyces cerevisiae is a ring-shaped
protease with seven ﬂexible subunits, Proc. Natl. Acad. Sci. U. S. A. 96 (1999)
6787–6790.
[21] S.S. Cha, Y.J. An, C.R. Lee, H.S. Lee, Y.G. Kim, S.J. Kim, K.K. Kwon, G.M. De Donatis,
J.H. Lee, M.R. Maurizi, S.G. Kang, Crystal structure of Lon protease: molecular
architecture of gated entry to a sequestered degradation chamber, EMBO J. 29
(2010) 3520–3530.
[22] R.E. Duman, J. Lowe, Crystal structures of Bacillus subtilis Lon protease, J. Mol.
Biol. 401 (2010) 653–670.
[23] R.T. Sauer, T.A. Baker, AAA+ proteases: ATP-fueled machines of protein
destruction, Annu. Rev. Biochem. 80 (2011) 587–612.
[24] M. Schmidt, A.N. Lupas, D. Finley, Structure and mechanism of ATP-dependent
proteases, Curr. Opin. Chem. Biol. 3 (1999) 584–591.
[25] O. Coux, K. Tanaka, A.L. Goldberg, Structure and functions of the 20S and 26S
proteasomes, Annu. Rev. Biochem. 65 (1996) 801–847.
[26] J. Walz, A. Erdmann, M. Kania, D. Typke, A.J. Koster, W. Baumeister, 26S
proteasome structure revealed by three-dimensional electron microscopy,
J. Struct. Biol. 121 (1998) 19–29.
[27] J. Adams, The proteasome: structure, function, and role in the cell, Cancer Treat.
Rev. 29 (Suppl. 1) (2003) 3–9.
[28] D. Voges, P. Zwickl, W. Baumeister, The 26S proteasome: a molecular machine
designed for controlled proteolysis, Annu. Rev. Biochem. 68 (1999) 1015–1068.
65S. Venkatesh et al. / Biochimica et Biophysica Acta 1823 (2012) 56–66[29] S.G. Kang, M.N. Dimitrova, J. Ortega, A. Ginsburg, M.R. Maurizi, Human
mitochondrial ClpP is a stable heptamer that assembles into a tetradecamer in
the presence of ClpX, J. Biol. Chem. 280 (2005) 35424–35432.
[30] S.G. Kang, J. Ortega, S.K. Singh, N. Wang, N.N. Huang, A.C. Steven, M.R. Maurizi,
Functional proteolytic complexes of the human mitochondrial ATP-dependent
protease, hClpXP, J. Biol. Chem. 277 (2002) 21095–21102.
[31] M.R. de Sagarra, I. Mayo, S. Marco, S. Rodriguez-Vilarino, J. Oliva, J.L. Carrascosa,
J.G. Castan, Mitochondrial localization and oligomeric structure of HClpP, the
human homologue of E. coli ClpP, J. Mol. Biol. 292 (1999) 819–825.
[32] S.G. Kang, M.R. Maurizi, M. Thompson, T. Mueser, B. Ahvazi, Crystallography and
mutagenesis point to an essential role for the N-terminus of human
mitochondrial ClpP, J. Struct. Biol. 148 (2004) 338–352.
[33] K. Leonhard, J.M. Herrmann, R.A. Stuart, G. Mannhaupt, W. Neupert, T. Langer,
AAA proteases with catalytic sites on opposite membrane surfaces comprise a
proteolytic system for the ATP-dependent degradation of inner membrane
proteins in mitochondria, EMBO J. 15 (1996) 4218–4229.
[34] T. Langer, AAA proteases: cellular machines for degrading membrane proteins,
Trends Biochem. Sci. 25 (2000) 247–251.
[35] I. Arnold, T. Langer, Membrane protein degradation by AAA proteases in
mitochondria, Biochim. Biophys. Acta 1592 (2002) 89–96.
[36] N. Wang, M.R. Maurizi, L. Emmert-Buck, M.M. Gottesman, Synthesis, processing,
and localization of human Lon protease, J. Biol. Chem. 269 (1994) 29308–29313.
[37] N. Wang, S. Gottesman, M.C. Willingham, M.M. Gottesman, M.R. Maurizi, A
human mitochondrial ATP-dependent protease that is highly homologous to
bacterial Lon protease, Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 11247–11251.
[38] I. Wagner, L. van Dyck, A.S. Savel'ev, W. Neupert, T. Langer, Autocatalytic
processing of the ATP-dependent PIM1 protease: crucial function of a pro-
region for sorting to mitochondria, EMBO J. 16 (1997) 7317–7325.
[39] T.V. Rotanova, E.E. Melnikov, A.G. Khalatova, O.V. Makhovskaya, I. Botos, A.
Wlodawer, A. Gustchina, Classiﬁcation of ATP-dependent proteases Lon and
comparison of the active sites of their proteolytic domains, Eur. J. Biochem.
271 (2004) 4865–4871.
[40] I. Botos, E.E. Melnikov, S. Cherry, J.E. Tropea, A.G. Khalatova, F. Rasulova, Z.
Dauter, M.R. Maurizi, T.V. Rotanova, A. Wlodawer, A. Gustchina, The catalytic
domain of Escherichia coli Lon protease has a unique fold and a Ser-Lys dyad in
the active site, J. Biol. Chem. 279 (2004) 8140–8148.
[41] I. Botos, E.E. Melnikov, S. Cherry, A.G. Khalatova, F.S. Rasulova, J.E. Tropea, M.R.
Maurizi, T.V. Rotanova, A. Gustchina, A. Wlodawer, Crystal structure of the
AAA+ alpha domain of E. coli Lon protease at 1.9A resolution, J. Struct. Biol.
146 (2004) 113–122.
[42] F.S. Rasulova, N.I. Dergousova, N.N. Starkova, E.E. Melnikov, L.D. Rumsh, L.M.
Ginodman, T.V. Rotanova, The isolated proteolytic domain of Escherichia coli
ATP-dependent protease Lon exhibits the peptidase activity, FEBS Lett. 432
(1998) 179–181.
[43] M. Li, A. Gustchina, F.S. Rasulova, E.E. Melnikov, M.R. Maurizi, T.V. Rotanova, Z.
Dauter, A. Wlodawer, Structure of the N-terminal fragment of Escherichia coli
Lon protease, Acta Crystallogr. D: Biol. Crystallogr. 66 (2010) 865–873.
[44] J. Garcia-Nafria, G. Ondrovicova, E. Blagova, V.M. Levdikov, J.A. Bauer, C.K.
Suzuki, E. Kutejova, A.J. Wilkinson, K.S. Wilson, Structure of the catalytic domain
of the human mitochondrial Lon protease: proposed relation of oligomer
formation and activity, Protein Sci. 19 (2010) 987–999.
[45] A.F. Neuwald, L. Aravind, J.L. Spouge, E.V. Koonin, AAA+: a class of chaperone-
like ATPases associated with the assembly, operation, and disassembly of
protein complexes, Genome Res. 9 (1999) 27–43.
[46] L. Waxman, A.L. Goldberg, Protease La, the lon gene product, cleaves speciﬁc
ﬂuorogenic peptides in an ATP-dependent reaction, J. Biol. Chem. 260 (1985)
12022–12028.
[47] A.S. Menon, L. Waxman, A.L. Goldberg, The energy utilized in protein breakdown
by the ATP-dependent protease (La) from Escherichia coli, J. Biol. Chem. 262
(1987) 722–726.
[48] S.G. Rudyak, T.E. Shrader, Polypeptide stimulators of the Ms-Lon protease,
Protein Sci. 9 (2000) 1810–1817.
[49] L. VanMelderen, M.H. Thi, P. Lecchi, S. Gottesman,M. Couturier, M.R. Maurizi, ATP-
dependent degradation of CcdA by Lon protease. Effects of secondary structure and
heterologous subunit interactions, J. Biol. Chem. 271 (1996) 27730–27738.
[50] L. Waxman, A.L. Goldberg, Protease La from Escherichia coli hydrolyzes ATP
and proteins in a linked fashion, Proc. Natl. Acad. Sci. U. S. A. 79 (1982)
4883–4887.
[51] R. Glas, M. Bogyo, J.S. McMaster, M. Gaczynska, H.L. Ploegh, A proteolytic system
that compensates for loss of proteasome function, Nature 392 (1998) 618–622.
[52] J. Fishovitz, M. Li, H. Frase, J. Hudak, S. Craig, K. Ko, A.J. Berdis, C.K. Suzuki, I. Lee,
Active-site-directed chemical tools for proﬁling mitochondrial Lon protease,
ACS Chem. Biol. 6 (2011) 781–788.
[53] I. Lee, A.J. Berdis, Adenosine triphosphate-dependent degradation of a
ﬂuorescent lambda N substrate mimic by Lon protease, Anal. Biochem. 291
(2001) 74–83.
[54] M.R. Maurizi, Degradation in vitro of bacteriophage lambda N protein by Lon
protease from Escherichia coli, J. Biol. Chem. 262 (1987) 2696–2703.
[55] U. Teichmann, L. van Dyck, B. Guiard, H. Fischer, R. Glockshuber, W. Neupert, T.
Langer, Substitution of PIM1 protease in mitochondria by Escherichia coli Lon
protease, J. Biol. Chem. (1996) 10137–10142.
[56] J.S. Choy, L.L. Aung, A.W. Karzai, Lon protease degrades transfer-messenger
RNA-tagged proteins, J. Bacteriol. 189 (2007) 6564–6571.
[57] M. Gonzalez, E.G. Frank, A.S. Levine, R. Woodgate, Lon-mediated proteolysis of
the Escherichia coli UmuD mutagenesis protein: in vitro degradation and identi-
ﬁcation of residues required for proteolysis, Genes Dev. 12 (1998) 3889–3899.[58] E. Gur, R.T. Sauer, Recognition of misfolded proteins by Lon, a AAA(+) protease,
Genes Dev. 22 (2008) 2267–2277.
[59] I.M. Shah, R.E. Wolf Jr., Sequence requirements for Lon-dependent degradation
of the Escherichia coli transcription activator SoxS: identiﬁcation of the SoxS
residues critical to proteolysis and speciﬁc inhibition of in vitro degradation by
a peptide comprised of the N-terminal 21 amino acid residues, J. Mol. Biol. 357
(2006) 718–731.
[60] Y. Ishii, F. Amano, Regulation of SulA cleavage by Lon protease by the C-terminal
amino acid of SulA, histidine, Biochem. J. 358 (2001) 473–480.
[61] Y. Ishii, S. Sonezaki, Y. Iwasaki, Y. Miyata, K. Akita, Y. Kato, F. Amano, Regulatory
role of C-terminal residues of SulA in its degradation by Lon protease in
Escherichia coli, J. Biochem. 127 (2000) 837–844.
[62] J.H. Liao, Y.C. Lin, J. Hsu, A.Y. Lee, T.A. Chen, C.H. Hsu, J.L. Chir, K.F. Hua, T.H. Wu,
L.J. Hong, P.W. Yen, A. Chiou, S.H. Wu, Binding and cleavage of E. coli HUbeta by
the E. coli Lon protease, Biophys. J. 98 (2010) 129–137.
[63] G. Ondrovicova, T. Liu, K. Singh, B. Tian, H. Li, O. Gakh, D. Perecko, J. Janata, Z. Granot,
J. Orly, E. Kutejova, C.K. Suzuki, Cleavage site selection within a folded substrate by
the ATP-dependent lon protease, J. Biol. Chem. 280 (2005) 25103–25110.
[64] S.R. Barkow, I. Levchenko, T.A. Baker, R.T. Sauer, Polypeptide translocation by the
AAA+ ClpXP protease machine, Chem. Biol. 16 (2009) 605–612.
[65] S. Licht, I. Lee, Resolving individual steps in the operation of ATP-dependent
proteolytic molecular machines: from conformational changes to substrate
translocation and processivity, Biochemistry 47 (2008) 3595–3605.
[66] Y.I. Kim, R.E. Burton, B.M. Burton, R.T. Sauer, T.A. Baker, Dynamics of substrate
denaturation and translocation by the ClpXP degradation machine, Mol. Cell 5
(2000) 639–648.
[67] A. Martin, T.A. Baker, R.T. Sauer, Rebuilt AAA + motors reveal operating
principles for ATP-fuelled machines, Nature 437 (2005) 1115–1120.
[68] C. Lee, M.P. Schwartz, S. Prakash, M. Iwakura, A. Matouschek, ATP-dependent
proteases degrade their substrates by processively unraveling them from the
degradation signal, Mol. Cell 7 (2001) 627–637.
[69] C.M. Pickart, R.E. Cohen, Proteasomes and their kin: proteases in the machine
age, Nat. Rev. Mol. Cell Biol. 5 (2004) 177–187.
[70] J.A. Kenniston, T.A. Baker, J.M. Fernandez, R.T. Sauer, Linkage between ATP
consumption and mechanical unfolding during the protein processing reactions
of an AAA+ degradation machine, Cell 114 (2003) 511–520.
[71] A.L. Goldberg, R.P. Moerschell, C.H. Chung, M.R. Maurizi, ATP-dependent
protease La (lon) from Escherichia coli, Methods Enzymol. 244 (1994) 350–375.
[72] J. Wang, J.J. Song, M.C. Franklin, S. Kamtekar, Y.J. Im, S.H. Rho, I.S. Seong, C.S. Lee,
C.H. Chung, S.H. Eom, Crystal structures of the HslVU peptidase-ATPase complex
reveal an ATP-dependent proteolysis mechanism, Structure 9 (2001) 177–184.
[73] B.G. Reid, W.A. Fenton, A.L. Horwich, E.U. Weber-Ban, ClpA mediates directional
translocation of substrate proteins into the ClpP protease, Proc. Natl. Acad. Sci.
U. S. A. 98 (2001) 3768–3772.
[74] W. Nishii, T. Suzuki, M. Nakada, Y.T. Kim, T. Muramatsu, K. Takahashi, Cleavage
mechanism of ATP-dependent Lon protease toward ribosomal S2 protein, FEBS
Lett. 579 (2005) 6846–6850.
[75] J. Patterson-Ward, J. Huang, I. Lee, Detection and characterization of two
ATP-dependent conformational changes in proteolytically inactive Escherichia
coli Lon mutants by stopped ﬂow kinetic techniques, Biochemistry 46 (2007)
13593–13605.
[76] D. Vineyard, J. Patterson-Ward, A.J. Berdis, I. Lee, Monitoring the timing of ATP
hydrolysis with activation of peptide cleavage in Escherichia coli Lon by transient
kinetics, Biochemistry 44 (2005) 1671–1682.
[77] S. Guha, L. Lopez-Maury, M. Shaw, J. Bahler, C.J. Norbury, V.R. Agashe,
Transcriptional and cellular responses to defective mitochondrial proteolysis
in ﬁssion yeast, J. Mol. Biol. 408 (2011) 222–237.
[78] M. Rep, J.M. van Dijl, K. Suda, G. Schatz, L.A. Grivell, C.K. Suzuki, Promotion of
mitochondrial membrane complex assembly by a proteolytically inactive yeast
Lon, Science 274 (1996) 103–106.
[79] I. Wagner, H. Arlt, L. van Dyck, T. Langer, W. Neupert, Molecular chaperones
cooperate with PIM1 protease in the degradation of misfolded proteins in
mitochondria, EMBO J. 13 (1994) 5135–5145.
[80] J.M. Bateman, M. Iacovino, P.S. Perlman, R.A. Butow, Mitochondrial DNA
instability mutants of the bifunctional protein Ilv5p have altered organization
in mitochondria and are targeted for degradation by Hsp78 and the Pim1p
protease, J. Biol. Chem. 277 (2002) 47946–47953.
[81] K. Rottgers, N. Zufall, B. Guiard, W. Voos, The ClpB homolog Hsp78 is required for
the efﬁcient degradation of proteins in the mitochondrial matrix, J. Biol. Chem.
277 (2002) 45829–45837.
[82] M. Schmitt, W. Neupert, T. Langer, Hsp78, a Clp homologue within
mitochondria, can substitute for chaperone functions of mt-hsp70, EMBO J. 14
(1995) 3434–3444.
[83] T. Major, B. von Janowsky, T. Ruppert, A. Mogk, W. Voos, Proteomic analysis of
mitochondrial protein turnover: identiﬁcation of novel substrate proteins of
the matrix protease pim1, Mol. Cell. Biol. 26 (2006) 762–776.
[84] A. Bayot, M. Gareil, A. Rogowska-Wrzesinska, P. Roepstorff, B. Friguet, A.L.
Bulteau, Identiﬁcation of novel oxidized protein substrates and physiological
partners of the mitochondrial ATP-dependent Lon-like protease Pim1, J. Biol.
Chem. 285 (2010) 11445–11457.
[85] T. Bender, I. Lewrenz, S. Franken, C. Baitzel, W. Voos, Mitochondrial enzymes are
protected from stress-induced aggregation by mitochondrial chaperones and
the Pim1/LON protease, Mol. Biol. Cell 22 (2011) 541–554.
[86] T. Bender, C. Leidhold, T. Ruppert, S. Franken, W. Voos, The role of protein quality
control in mitochondrial protein homeostasis under oxidative stress, Proteomics
10 (2010) 1426–1443.
66 S. Venkatesh et al. / Biochimica et Biophysica Acta 1823 (2012) 56–66[87] D.A. Bota, K.J. Davies, Lon protease preferentially degrades oxidized mitochon-
drial aconitase by an ATP-stimulated mechanism, Nat. Cell Biol. 4 (2002)
674–680.
[88] B. Guillon, A.L. Bulteau, M. Wattenhofer-Donze, S. Schmucker, B. Friguet, H.
Puccio, J.C. Drapier, C. Bouton, Frataxin deﬁciency causes upregulation of
mitochondrial Lon and ClpP proteases and severe loss of mitochondrial Fe-S
proteins, FEBS J. 276 (2009) 1036–1047.
[89] K. Luce, H.D. Osiewacz, Increasing organismal healthspan by enhancing mito-
chondrial protein quality control, Nat. Cell Biol. 11 (2009) 852–858.
[90] D.A. Bota, H. Van Remmen, K.J. Davies, Modulation of Lon protease activity and
aconitase turnover during aging and oxidative stress, FEBS Lett. 532 (2002)
103–106.
[91] L. Stanyer, W. Jorgensen, O. Hori, J.B. Clark, S.J. Heales, Inactivation of brain
mitochondrial Lon protease by peroxynitrite precedes electron transport chain
dysfunction, Neurochem. Int. 53 (2008) 95–101.
[92] E. Kutejova, G. Durcova, E. Surovkova, S. Kuzela, Yeast mitochondrial
ATP-dependent protease: puriﬁcation and comparison with the homologous rat
enzyme and the bacterial ATP-dependent protease La, FEBS Lett. 329 (1993) 47–50.
[93] J.E. Aldridge, T. Horibe, N.J. Hoogenraad, Discovery of genes activated by the
mitochondrial unfolded protein response (mtUPR) and cognate promoter
elements, PLoS One 2 (2007) e874.
[94] Q. Zhao, J. Wang, I.V. Levichkin, S. Stasinopoulos, M.T. Ryan, N.J. Hoogenraad, A
mitochondrial speciﬁc stress response in mammalian cells, EMBO J. 21 (2002)
4411–4419.
[95] T. Yoneda, C. Benedetti, F. Urano, S.G. Clark, H.P. Harding, D. Ron, Compartment-
speciﬁc perturbation of protein handling activates genes encoding mitochondri-
al chaperones, J. Cell Sci. 117 (2004) 4055–4066.
[96] T. Horibe, N.J. Hoogenraad, The chop gene contains an element for the positive
regulation of the mitochondrial unfolded protein response, PLoS One 2 (2007)
e835.
[97] Z. Granot, O. Kobiler, N. Melamed-Book, S. Eimerl, A. Bahat, B. Lu, S. Braun, M.R.
Maurizi, C.K. Suzuki, A.B. Oppenheim, J. Orly, Turnover of mitochondrial
steroidogenic acute regulatory (StAR) protein by Lon protease: the unexpected
effect of proteasome inhibitors, Mol. Endocrinol. 21 (2007) 2164–2177.
[98] F. Arakane, C.B. Kallen, H. Watari, J.A. Foster, N.B. Sepuri, D. Pain, S.E. Stayrook,
M. Lewis, G.L. Gerton, J.F. Strauss III, The mechanism of action of steroidogenic
acute regulatory protein (StAR). StAR acts on the outside of mitochondria to
stimulate steroidogenesis, J. Biol. Chem. 273 (1998) 16339–16345.
[99] F. Arakane, T. Sugawara, H. Nishino, Z. Liu, J.A. Holt, D. Pain, D.M. Stocco,W.L. Miller,
J.F. Strauss III, Steroidogenic acute regulatory protein (StAR) retains activity in the
absence of its mitochondrial import sequence: implications for the mechanism of
StAR action, Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 13731–13736.
[100] C. Handschin, J. Lin, J. Rhee, A.K. Peyer, S. Chin, P.H. Wu, U.A. Meyer, B.M.
Spiegelman, Nutritional regulation of hepatic heme biosynthesis and porphyria
through PGC-1alpha, Cell 122 (2005) 505–515.
[101] J. Zheng, Y. Shan, R.W. Lambrecht, S.E. Donohue, H.L. Bonkovsky, Differential
regulation of human ALAS1 mRNA and protein levels by heme and cobalt
protoporphyrin, Mol. Cell. Biochem. 319 (2008) 153–161.
[102] T.A. Dailey, J.H. Woodruff, H.A. Dailey, Examination of mitochondrial protein
targeting of haem synthetic enzymes: in vivo identiﬁcation of three functional
haem-responsive motifs in 5-aminolaevulinate synthase, Biochem. J. 386
(2005) 381–386.
[103] Q. Tian, T. Li, W. Hou, J. Zheng, L.W. Schrum, H.L. Bonkovsky, Lon Peptidase 1
(LONP1)-dependent breakdown of mitochondrial 5-aminolevulinic acid synthase
protein by heme in human liver cells, J. Biol. Chem. 286 (2011) 26424–26430.
[104] A. Kuroda, K. Nomura, R. Ohtomo, J. Kato, T. Ikeda, N. Takiguchi, H. Ohtake, A.
Kornberg, Role of inorganic polyphosphate in promoting ribosomal protein
degradation by the Lon protease in E. coli, Science 293 (2001) 705–708.
[105] A. Kuroda, K. Nomura, N. Takiguchi, J. Kato, H. Ohtake, Inorganic polyphosphate
stimulates lon-mediated proteolysis of nucleoid proteins in Escherichia coli, Cell.
Mol. Biol. (Noisy-le-grand) 52 (2006) 23–29.
[106] K. Nomura, J. Kato, N. Takiguchi, H. Ohtake, A. Kuroda, Effects of inorganic
polyphosphate on the proteolytic and DNA-binding activities of Lon in
Escherichia coli, J. Biol. Chem. 279 (2004) 34406–34410.
[107] M.F. Charette, G.W. Henderson, L.L. Doane, A. Markovitz, DNA-stimulated
ATPase activity on the lon (CapR) protein, J. Bacteriol. 158 (1984) 195–201.
[108] C.H. Chung, A.L. Goldberg, DNA stimulates ATP-dependent proteolysis and
protein-dependent ATPase activity of protease La from Escherichia coli, Proc.
Natl. Acad. Sci. U. S. A. 79 (1982) 795–799.
[109] Y.C. Lin, H.C. Lee, I. Wang, C.H. Hsu, J.H. Liao, A.Y. Lee, C. Chen, S.H. Wu, DNA-
binding speciﬁcity of the Lon protease alpha-domain from Brevibacillus
thermoruber WR-249, Biochem. Biophys. Res. Commun. 388 (2009) 62–66.[110] G.K. Fu, M.J. Smith, D.M. Markovitz, Bacterial protease Lon is a site-speciﬁc DNA-
binding protein, J. Biol. Chem. 272 (1997) 534–538.
[111] B.A. Zehnbauer, E.C. Foley, G.W. Henderson, A. Markovitz, Identiﬁcation and
puriﬁcation of the Lon+ (capR+) gene product, a DNA-binding protein, Proc.
Natl. Acad. Sci. U. S. A. 78 (1981) 2043–2047.
[112] S. Sonezaki, K. Okita, T. Oba, Y. Ishii, A. Kondo, Y. Kato, Protein substrates and
heat shock reduce the DNA-binding ability of Escherichia coli Lon protease,
Appl. Microbiol. Biotechnol. 44 (1995) 484–488.
[113] T. Simonsson, P. Pecinka, M. Kubista, DNA tetraplex formation in the control
region of c-myc, Nucleic Acids Res. 26 (1998) 1167–1172.
[114] A. Siddiqui-Jain, C.L. Grand, D.J. Bearss, L.H. Hurley, Direct evidence for a
G-quadruplex in a promoter region and its targeting with a small molecule to
repress c-MYC transcription, Proc. Natl. Acad. Sci. U. S. A. 99 (2002)
11593–11598.
[115] P. Rawal, V.B. Kummarasetti, J. Ravindran, N. Kumar, K. Halder, R. Sharma, M.
Mukerji, S.K. Das, S. Chowdhury, Genome-wide prediction of G4 DNA as
regulatory motifs: role in Escherichia coli global regulation, Genome Res. 16
(2006) 644–655.
[116] J.S. Schlehe, A.K. Lutz, A. Pilsl, K. Lammermann, K. Grgur, I.H. Henn, J. Tatzelt, K.F.
Winklhofer, Aberrant folding of pathogenic Parkin mutants: aggregation versus
degradation, J. Biol. Chem. 283 (2008) 13771–13779.
[117] K.F. Winklhofer, J. Tatzelt, C. Haass, The two faces of protein misfolding: gain-
and loss-of-function in neurodegenerative diseases, EMBO J. 27 (2008)
336–349.
[118] L.M. Luheshi, C.M. Dobson, Bridging the gap: from protein misfolding to protein
misfolding diseases, FEBS Lett. 583 (2009) 2581–2586.
[119] C.B. Pedersen, P. Bross, V.S. Winter, T.J. Corydon, L. Bolund, K. Bartlett, J. Vockley,
N. Gregersen, Misfolding, degradation, and aggregation of variant proteins.
The molecular pathogenesis of short chain acyl-CoA dehydrogenase (SCAD)
deﬁciency, J. Biol. Chem. 278 (2003) 47449–47458.
[120] C.B. Pedersen, S. Kolvraa, A. Kolvraa, V. Stenbroen, M. Kjeldsen, R. Ensenauer, I.
Tein, D. Matern, P. Rinaldo, C. Vianey-Saban, A. Ribes, W. Lehnert, E. Christensen,
T.J. Corydon, B.S. Andresen, S. Vang, L. Bolund, J. Vockley, P. Bross, N. Gregersen,
The ACADS gene variation spectrum in 114 patients with short-chain acyl-CoA
dehydrogenase (SCAD) deﬁciency is dominated by missense variations leading
to protein misfolding at the cellular level, Hum. Genet. 124 (2008) 43–56.
[121] M. Nielsen, C. Lundegaard, O. Lund, T.N. Petersen, CPHmodels-3.0–remote
homology modeling using structure-guided sequence proﬁles, Nucleic Acids
Res. 38 (2010) W576–W581.
[122] M. Levitt, Accurate modeling of protein conformation by automatic segment
matching, J. Mol. Biol. 226 (1992) 507–533.
[123] M. Levitt, Protein folding by restrained energy minimization and molecular
dynamics, J. Mol. Biol. 170 (1983) 723–764.
[124] C. Lee, S. Subbiah, Prediction of protein side-chain conformation by packing
optimization, J. Mol. Biol. 217 (1991) 373–388.
[125] J. Gasteiger, M. Marsili, A new model for calculating atomic charges in
molecules, Tetrahedron Lett. (1978) 3181–3184.
[126] J. Gasteiger, M. Marsili, Iterative Partial Equalization of Orbital Electronegativity -
A Rapid Access to Atomic Charges, Tetrahedron 36 (1980) 3219–3228.
[127] S.B. Wu, Y.S. Ma, Y.T. Wu, Y.C. Chen, Y.H. Wei, Mitochondrial DNA mutation-
elicited oxidative stress, oxidative damage, and altered gene expression in
cultured cells of patients with MERRF syndrome, Mol. Neurobiol. 41 (2010)
256–266.
[128] S. Felk, S. Ohrt, L. Kussmaul, A. Storch, F. Gillardon, Activation of the mitochon-
drial protein quality control system and actin cytoskeletal alterations in cells
harbouring the MELAS mitochondrial DNA mutation, J. Neurol. Sci. 295 (2010)
46–52.
[129] H.M. Wang, K.C. Cheng, C.J. Lin, S.W. Hsu, W.C. Fang, T.F. Hsu, C.C. Chiu, H.W.
Chang, C.H. Hsu, A.Y. Lee, Obtusilactone A and (−)-sesamin induce apoptosis
in human lung cancer cells by inhibiting mitochondrial Lon protease and
activating DNA damage checkpoints, Cancer Sci. 101 (2010) 2612–2620.
[130] M. Pinti, L. Gibellini, G. Guaraldi, G. Orlando, T.W. Gant, E. Morselli, M. Nasi, P.
Salomoni, C. Mussini, A. Cossarizza, Upregulation of nuclear-encoded mitochon-
drial LON protease in HAART-treated HIV-positive patients with lipodystrophy:
implications for the pathogenesis of the disease, AIDS 24 (2010) 841–850.
[131] K. Fukada, F. Zhang, A. Vien, N.R. Cashman, H. Zhu, Mitochondrial proteomic
analysis of a cell line model of familial amyotrophic lateral sclerosis, Mol. Cell.
Proteomics 3 (2004) 1211–1223.
[132] J. Hansen, T.J. Corydon, J. Palmfeldt, A. Durr, B. Fontaine, M.N. Nielsen, J.H.
Christensen, N. Gregersen, P. Bross, Decreased expression of the mitochondrial
matrix proteases Lon and ClpP in cells from a patient with hereditary spastic
paraplegia (SPG13), Neuroscience 153 (2008) 474–482.
